|
|
|
|
|
|
|
|
|
|
|
|
|
30.07.26 - 22:54
|
DexCom Inc. Reveals Advance In Q2 Income (AFX)
|
|
|
WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM) reported a profit for its second quarter that Increases, from last yearThe company's earnings totaled $249.1 million, or $0.64 per share. This compares wi......
|
|
|
30.07.26 - 22:03
|
Dexcom Reports Second Quarter 2026 Financial Results (Business Wire)
|
|
|
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2026.
Second Quarter 2026 Financial Highlights:
Revenue grew 13% year-over-year to $1.308 billion on a reported basis and 12% year-over-year on an organic1 basis.
U.S. revenue grew 11% and international revenue grew 19% on a reported basis and 16% on an organic1 basis, all on a year-over-year basis.
GAAP operating income of $318.3 million or 24.3% of revenue, an increase of 590 basis points compared to the second quarter of 2025. Non-GAAP operating income* of $328.3 million or 25.1% of reported revenue, an increase of 590 basis points compared to the second quarter of 2025.
Second Quarter 2026 Strategic Highlights:
Hosted 2026 Investor Day, highlighting market opportunities, business strategy, innovation efforts, and a new long-term financial outlook.
Announced positive results from the CONNECT randomized controlled trial, demonstrating that Dexcom CGM use among people with...
|
|
|
|
|
|
|
|
|
|
|
|
|
09.07.26 - 14:36
|
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time (Business Wire)
|
|
|
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.About DexCom, Inc.Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes an...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
